The global mouth ulcer treatment market size was estimated to be worth USD 1.6 billion in 2021. The market is expected to rise at a growth rate of 3.9% in the forecast period of 2023-2031. By 2030, the market value is anticipated to be worth USD 2.3 billion. The rising awareness of oral hygiene and the growing geriatric population are driving market growth.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
A mouth ulcer is a disorder associated with oral hygiene causing sores and lesions in the lips, palate, gums, and inner cheeks. Mouth ulcers are also called canker sores or aphthous ulcers.
Mouth ulcers are one of the most common diseases affecting nearly 20 per cent of the population at one point. The signs and symptoms of mouth ulcers are visible and appear as red, white, grey, or yellow sores in the mouth or around the lips. Other symptoms include light to moderate pain, increased soreness, swelling, and difficulty, while eating and brushing.
The exact cause of mouth ulcers is unknown but is set to be triggered by several factors including minor tissue injury, allergic reaction, orthodontic braces, hormonal changes, bacterial, viral or fungal infections, vitamin deficiencies, stress and lack of sleep.
Mouth ulcers are diagnosed with the help of visual examination and in severe cases, with the incorporation of blood tests to assess the levels of vitamins and minerals. Mouth ulcers are generally treated with the help of topical treatments including steroid ointments, antiseptic gels, and medicated mouth rinses.
In very rare cases, the mouth soar may turn into a chronic condition called oral cancer, which is visible above or below the tongue.
According to this study, the mouth ulcer treatment market can be categorised into the following segments:
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Breakup by Drug Class
Market Breakup by Formulation Type
Market Breakup by Indication Type
Market Breakup by Distribution Channel
Market Breakup by Region
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The mouth ulcer treatment market is primarily driven by the rising prevalence of disorders associated with oral hygiene. These disorders are increased with the rise in the consumption of tobacco and other products and smoking cessation. According to reports by the National Library of Medicine, the prevalence rate of oral ulcers was estimated to be 9% in children, which is expected to rise in the forecast period.
The market is further driven by the increasing adoption of chemical-based toothpaste, growing oral hygiene awareness and a rising geriatric population. Additionally, the increasing demand for more advanced and effective treatments is also expected to bolster market growth.
Other factors include poor oral hygiene, high stress, unhealthy lifestyles, oral infection or injury and lack of sleep are expected to increase the incidence of mouth ulcers. This is anticipated to fuel the mouth ulcer treatment market growth.
Among the available formulations, the mouthwash segment is projected to dominate the market share. Medicated and non-medicated mouthwashes play a vital role in the management of canker sores by killing the microbial agents present in the mouth. The major key players and pharmaceutical companies are introducing several ayurvedic and flavoured mouthwashes which are expected to escalate the mouth ulcer treatment market demand during the forecast period.
North America is expected to hold the largest share of the market owing to the rising incidence of ulcers, the availability of advanced technologies, and growing awareness. For example, MouthWatch, a key market player discovered an HD intra-oral camera in Las Vegas, which will assist the dentist in proper diagnosis and treatment. This will attribute to the market growth of this region.
The treatment of mouth ulcers is simple and in maximum cases, can be done with the help of oral and topical medications along with several home remedies. The mouth ulcer treatment market is attributed to both preventative and therapeutic care. The treatment regimen depends on the type of ulcer and type of patient.
Mouth ulcers can be treated by non-steroidal anti-inflammatory drugs, such as ibuprofen and topical analgesics, like benzydamine mouthwash. These drugs are used for the management of light to moderate pain and provide temporary relief.
Certain types of mouthwashes, chlorhexidine, possess antiseptic properties, are used for the treatment of mouth ulcers. These help in killing microbial growth and thus prevent the further progression of infection.
Topical gels, creams, and systemic steroids are also used to reduce inflammation. The antifungal drug is used to prevent oral candidiasis in patients taking prolonged steroids. For the treatment of recurrent ulcers, vitamin B12 has been found effective. Immunosuppressants are sometimes used for the treatment of severe mouth ulcers.
Further, preventative strategies are implemented to prevent mouth ulcer disease. This includes avoiding spicy foods, eating a well-balanced diet, and maintaining proper oral hygiene.
Manx Healthcare, a key market player has recently discovered Oral Soothe and Sore Throat 0.15% w/v mouthwash to manage the mouth and throat pain caused by various medical disorders, such as gum disease, mouth ulcers, dental surgery, and oral cancers.
GELX Oral Gel is a novel topical medication launched by US WorldMeds LLC for the treatment of oral pain associated with the disorders associated with the oral cavity. The gel is based on the zinc-taurine bioactive barrier therapy and will assist in the management of oral ulcers.
With extensive research and innovation, Implant Dentistry has launched a novel mouthwash rinse, Clinicept to protect oral mucosa and cavity from bacterial, fungal, and viral contamination.
Recently, ICPA Health Products has launched a novel medicated toothpaste, Trioplast for the treatment of mouth ulcers. Trioplast acts by lowering the swelling in the mouth by reducing the allergic reaction. This is expected to benefit the inflammatory diseases associated with the oral cavity.
The discovery of these novel therapeutic interventions will assist in the proper diagnosis and treatment of mouth ulcers. The novel product launches will facilitate the expansion of the market.
The report gives an in-depth analysis of the key players involved in the mouth ulcers treatment market, sponsors manufacturing the therapies, and putting them through trials to get FDA approvals. The companies included in the market are as follows:
|Scope of the Report||
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|Breakup by Drug Class||
|Breakup by Formulation Type||
|Breakup by Indication Type||
|Breakup by Distribution Channel||
|Breakup by Region||
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
2 Research Methodology
3 Executive Summary
4 Global Mouth Ulcer Overview
4.1 Guidelines and Stages
4.3 Screening and Diagnosis
4.4 Treatment Pathway
5 Patient Profile
5.1 Patient Profile Overview
5.2 Patient Psychology and Emotional Impact Factors
5.3 Risk Assessment and Treatment Success Rate
6 Current Scenario Evaluation and Regulatory Framework
6.1 Emerging Therapies and Clinical Trials
6.2 Patent Landscape
6.2.1 Patent Overview
126.96.36.199 Patent Status and Expiry
188.8.131.52 Timelines from Drug Development to Commercial Launch
184.108.40.206 New Drug Application
220.127.116.11.1 Documentation and Approval Process
6.3 Cost of Treatment
6.4 Regulatory Framework
6.4.1 Regulatory Overview
18.104.22.168 US FDA
22.214.171.124 EU EMA
126.96.36.199 INDIA CDSCO
188.8.131.52 JAPAN PMDA
7 Challenges and Unmet Needs
7.1 Treatment Pathway Challenges
7.2 Compliance and Drop-Out Analysis
7.3 Awareness and Prevention Gaps
8 Global Mouth Ulcer Treatment market
8.1 Global Mouth Ulcer Treatment Market Overview
8.2 Global Mouth Ulcer Treatment Market Analysis
8.2.1 Market Overview
184.108.40.206 Global Mouth Ulcer Treatment Market Historical Value (2016-2022)
220.127.116.11 Global Mouth Ulcer Treatment Market Forecast Value (2023-2031)
8.2.2 Global Mouth Ulcer Treatment Market by Drug Class
18.104.22.168 Market Overview
22.214.171.124.1 Analgesics and Corticosteroids
8.2.3 Global Mouth Ulcer Treatment Market by Formulation Type
126.96.36.199 Market Overview
8.2.4 Global Mouth Ulcer Treatment Market by Indication Type
188.8.131.52 Market Overview
184.108.40.206.1 Aphthous Stomatitis
220.127.116.11.2 Oral Lichen Planus
8.2.5 Global Mouth Ulcer Treatment Market by Distribution Channel
18.104.22.168 Market Overview
22.214.171.124.1 Hospital Pharmacies
126.96.36.199.2 Retail Pharmacies
188.8.131.52.3 Online Pharmacies
8.2.6 Global Mouth Ulcer Treatment Market by Region
184.108.40.206 Market Overview
220.127.116.11.1 North America
18.104.22.168.3 Asia Pacific
22.214.171.124.4 Middle East and Africa
126.96.36.199.5 Latin America
9 North America Mouth Ulcer Treatment Market
9.1 Market Share by Country
9.2 United States of America
9.2.1 Historical Trend (2016-2022)
9.2.2 Forecast Trend (2023-2031)
9.3.1 Historical Trend (2016-2022)
9.3.2 Forecast Trend (2023-2031)
10 Europe Mouth Ulcer Treatment Market
10.1 Market Share by Country
10.2 United Kingdom
10.2.1 Historical Trend (2016-2022)
10.2.2 Forecast Trend (2023-2031)
10.3.1 Historical Trend (2016-2022)
10.3.2 Forecast Trend (2023-2031)
10.4.1 Historical Trend (2016-2022)
10.4.2 Forecast Trend (2023-2031)
10.5.1 Historical Trend (2016-2022)
10.5.2 Forecast Trend (2023-2031)
11 Asia Pacific Mouth Ulcer Treatment Market
11.1 Market Share by Country
11.2.1 Historical Trend (2016-2022)
11.2.2 Forecast Trend (2023-2031)
11.3.1 Historical Trend (2016-2022)
11.3.2 Forecast Trend (2023-2031)
11.4.1 Historical Trend (2016-2022)
11.4.2 Forecast Trend (2023-2031)
11.5.1 Historical Trend (2016-2022)
11.5.2 Forecast Trend (2023-2031)
11.6.1 Historical Trend (2016-2022)
11.6.2 Forecast Trend (2023-2031)
12 Latin America Mouth Ulcer Treatment Market
12.1 Market Share by Country
12.2.1 Historical Trend (2016-2022)
12.2.2 Forecast Trend (2023-2031)
12.3.1 Historical Trend (2016-2022)
12.3.2 Forecast Trend (2023-2031)
12.4.1 Historical Trend (2016-2022)
12.4.2 Forecast Trend (2023-2031)
13 Middle East and Africa Mouth Ulcer Treatment Market
13.1 Market Share by Country
13.2 Saudi Arabia
13.2.1 Historical Trend (2016-2022)
13.2.2 Forecast Trend (2023-2031)
13.3 United Arab Emirates
13.3.1 Historical Trend (2016-2022)
13.3.2 Forecast Trend (2023-2031)
13.4.1 Historical Trend (2016-2022)
13.4.2 Forecast Trend (2023-2031)
13.5 South Africa
13.5.1 Historical Trend (2016-2022)
13.5.2 Forecast Trend (2023-2031)
14 Global Mouth Ulcer Treatment Market Dynamics
14.1 Market Drivers and Constraints
14.2 SWOT Analysis
14.3 Porter’s Five Forces Model
14.4 Key Demand Indicators
14.5 Key Price Indicators
14.6 Industry Events, Initiatives & Trends
14.7 Value Chain Analysis
15 Supplier Landscape
15.1 Sunstar Suisse S.A.
15.1.1 Company Overview
15.1.2 Product Portfolio
15.1.3 Demographic Reach and Achievements
15.1.4 Mergers and Acquisitions
15.2 Reckitt Benckiser Group PLC
15.2.1 Company Overview
15.2.2 Product Portfolio
15.2.3 Demographic Reach and Achievements
15.2.4 Mergers and Acquisitions
15.3 Pfizer, Inc
15.3.1 Company Overview
15.3.2 Product Portfolio
15.3.3 Demographic Reach and Achievements
15.3.4 Mergers and Acquisitions
15.4 Blistex Inc
15.4.1 Company Overview
15.4.2 Product Portfolio
15.4.3 Demographic Reach and Achievements
15.4.4 Mergers and Acquisitions
15.5 Bristol-Myers Squibb Company
15.5.1 Company Overview
15.5.2 Product Portfolio
15.5.3 Demographic Reach and Achievements
15.5.4 Mergers and Acquisitions
15.6 GSK plc
15.6.1 Company Overview
15.6.2 Product Portfolio
15.6.3 Demographic Reach and Achievements
15.6.4 Mergers and Acquisitions
15.7 Church & Dwight Co., Inc.
15.7.1 Company Overview
15.7.2 Product Portfolio
15.7.3 Demographic Reach and Achievements
15.7.4 Mergers and Acquisitions
15.8 Colgate-Palmolive Company
15.8.1 Company Overview
15.8.2 Product Portfolio
15.8.3 Demographic Reach and Achievements
15.8.4 Mergers and Acquisitions
15.9 Dr Reddy’s Laboratories Ltd.
15.9.1 Company Overview
15.9.2 Product Portfolio
15.9.3 Demographic Reach and Achievements
15.9.4 Mergers and Acquisitions
15.10 Patterson Companies, Inc
15.10.1 Company Overview
15.10.2 Product Portfolio
15.10.3 Demographic Reach and Achievements
15.10.4 Mergers and Acquisitions
15.11 Prince Care Pharma Pvt Ltd.
15.11.1 Company Overview
15.11.2 Product Portfolio
15.11.3 Demographic Reach and Achievements
15.11.4 Mergers and Acquisitions
15.12.1 Company Overview
15.12.2 Product Portfolio
15.12.3 Demographic Reach and Achievements
15.12.4 Mergers and Acquisitions
16 Global Mouth Ulcer Treatment Market Distribution Model (Additional Insight)
16.2 Potential Distributors
16.3 Key Parameters for Distribution Partner Assessment
17 Payment Methods (Additional Insight)
17.1 Government Funded
17.2 Private Insurance
*Additional insights provided are customizable as per client requirements.
The market is primarily driven by the increasing prevalence of mouth ulcers, novel product launches and approvals and increasing consumption of tobacco and smoking cessation.
North America is anticipated to hold a maximum share of the market during the forecast period.
Based on the drug class, the market is categorised into analgesics and corticosteroids, antihistamines, antimicrobials, anaesthetics, and others.
Based on the formulation type, the market is segmented into sprays, mouthwashes, gels, lozenges, and others.
Based on the indication type, the market is segmented into aphthous stomatitis, oral lichen planus and others.
Based on the distribution channel, the market is divided into hospital pharmacies, retail pharmacies, online pharmacies, and others.
The different regions in the market are North America, Europe, Asia Pacific, Latin America and the Middle East and Africa.
The key companies involved in the market are Sunstar Suisse S.A., Reckitt Benckiser Group PLC, Pfizer, Inc, Blistex Inc, Bristol-Myers Squibb Company, GSK plc, Church & Dwight Co., Inc., Colgate-Palmolive Company, Dr Reddy’s Laboratories Ltd., Patterson Companies, Inc, Prince Care Pharma Pvt Ltd., 3M, among others.
Single User License
Five User License
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.